Cerecor Stock Predictions

Healthcare > Biotechnology

Buy CERC

*Your capital is at risk

$0.319

+0.0060 (+1.92%)

At Close: May 27, 2022

Currently predicting for Mon, 8 Jun 2026

CERC Prediction Chart

CERC Predictions History

Latest community submissions for CERC.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
Robin.Reeve.17503	Jul 5, 2018	$4.82 +0.42%	$4.80	X	99.60%	4
Vishal.Duggal.20736	Feb 28, 2018	$5.70 +22.32%	$4.66	X	77.70%	0
Simon.Mikhail.20732	Feb 28, 2018	$6.20 +33.05%	$4.66	X	67.00%	0
ZP Pro	Dec 26, 2017	$6.69 +101.51% Unrealistic Excluded from avg	$3.32	X	0.00%	0
JS Pro	Dec 26, 2017	$2.65 -20.18%	$3.32	X	79.80%	0
Suresh @Suresh.16295	Dec 26, 2017	$2.78 -16.27%	$3.32	X	83.70%	0
JS Pro	Nov 30, 2017	$1.73 -2.81%	$1.78	X	97.20%	0
Balagurubaran	Nov 30, 2017	$1.40 -21.35%	$1.78	X	78.70%	0
JuanC Villegas Pro	Nov 30, 2017	$1.51 -15.17%	$1.78	X	84.80%	0
Victor..Li.8930 Merchant	Aug 28, 2017	$0.735 +3.49%	$0.710	V	96.50%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CERC with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CERECOR INC.

Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
FISV	0%	Nov 30
K KEEL	0%	Nov 30
D DFTX	0%	Nov 30
R RKLZ	0%	Nov 30
R RKTO	0%	Nov 30

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by